Acetylcholinesterase (AChE) is the enzyme that hydrolyzes the neurotransmitter acetylcholine at cholinergic synapses and neuromuscular junctions. However, results from our laboratory and others indicate that AChE has an extrasynaptic, noncholinergic role during neural development. This article is a review of our findings demonstrating the morphogenic role of AChE, using a neuronal cell culture model. We also discuss how these data suggest that AChE has a cell adhesive function during neural development. These results could have additional significance as AChE is the target enzyme of agricultural organophosphate and carbamate pesticides as well as the commonly used household organophosphate chlorpyrifos (Dursban). Prenatal exposure to these agents could have adverse effects on neural development by interfering with the morphogenic function of AChE. -Environ Health Perspect 107(Suppl 1): 81-87 (1999). http.//ehpnetl.niehs.nih.gov/docs/1999/Suppl-1/81-B7bigbee/abstract.html
Accumulating evidence indicates that acetylcholinesterase (AChE) has extrasynaptic functions during neural development (1) (2) (3) . This idea was initially based on in vivo observations that AChE is transiently expressed by neurons throughout periods of axonal outgrowth prior to synaptogenesis, a period during which the classical cholinolytic role for AChE in terminating nervous transmission is unnecessary. For example, in the central nervous system (CNS), Robertson and colleagues (3, 4) have demonstrated transient AChE activity in thalamic neurons at a time when their axons are growing into the cerebral cortex. Similar results have been reported by Kristt (5) in rat and by Kostovic and colleagues in developing primates (6) . This expression of AChE has also been confirmed at the messenger RNA level by in situ hybridization (7) . In the chick, transient AChE expression occurs in developing spinal cord neurons, which coincides with Manuscript received at EHP 6 August 1998; accepted 13 October 1998. Address correspondence to J. W. Bigbee axonal outgrowth from these cells (1, 8, 9) . In the peripheral nervous system (PNS), AChE is transiently expressed by developing dorsal root ganglion (DRG) neurons (10) (11) (12) (13) (14) and later in their axons and growth cones in the spinal cord (15, 16 (18) . BW284c51 is a bis-quaternary nitrogen compound that is a highly specific inhibitor for AChE. Because of this specificity, BW284c51 is routinely used to confirm AChE activity in both histochemical and biochemical determinations. Physostigmine is a naturally occurring carbamate inhibitor of AChE. These two compounds were used because they inhibit AChE activity by different mechanisms. Medium with or without inhibitors was changed daily. BW284c51 is used to confirm AChE activity and as a control for inhibitor treatment, the butyrylcholinesterase (BChE) inhibitor tetraisopropyl pyrophosphoramide (iso-OMPA) substituted for either BW284c51 or physostigmine. BChE was not expressed in DRG neurons either at the developmental stage when they were removed from the embryo (14) or after the cells were placed in culture (18) . Cultures were maintained for 14 days and then examined by darkfield microscopy to determine the extent and pattern of outgrowth and by transmission electron microscopy to reveal ultrastructural changes. In addition, to assess the distribution of neurofilaments, the major cytoskeletal component of neurons, cultures were examined by immunofluorescence microscopy as previously described (19, 20) , using a monoclonal antibody to the low molecular weight neurofilament subunit protein NF68. 
Monodonal Antibody Treatment

AChE Assays
AChE activity was detected histochemically as previously described (18, 19, 21) , using acetylthiocholine as the substrate analog according to the modification of the method of El Badawi and Schenk (24) . AChE activity was quantified either by colorimetric analysis based on the method of Ellman et al. (25) , using acetylthiocholine, or by radiometric assay, using tritiated acetylcholine, according to the method of Hall (26) as we have previously described (18, 21) .
Results
The Level ofAChE Expresion
Correlates with Neurite Outgrowth Cultured DRG neurons showed a developmental increase in AChE that paralleled the extent of neurite outgrowth ( Figure 1 ). AChE expression increased 5-fold between 3 and 7 days in culture (17, 18) , which is consistent with the developmental expression ofAChE by DRG neurons in vivo (10, 14) .
Parmacologic Inhibitor Treatment
Reduces Neurite Outgrowth DRG neurons displayed a dose-dependent reduction in outgrowth in the presence of either BW284c5 1 or physostigmine ( Figure 2 ). No effect on outgrowth was observed when iso-OMPA was substituted for either of these inhibitors. With increasing doses the outgrowth decreased and appeared more fasciculated than in control cultures. For both compounds, at the highest doses tested, minimal neurite outgrowth was observed beyond the central plating area. These results were not due to differential cell survival as no difference in cell number was found between control and treated cultures at the completion of the experiments. Furthermore, this effect was reversible as additional outgrowth occurred and appeared normal after removal of either inhibitor. The inhibitor concentrations used in these studies were consistent with values reported in the literature (27) for inhibition of AChE in vitro. The results clearly indicate that the level of AChE inhibition closely correlated with the extent of decreased outgrowth ( Figure  3 ). Interestingly, co-administration of 1 mM dibutyryl cyclic adenosine monophosphate (cAMP) along with BW284c5 1 significantly increased both neurite outgrowth and AChE expression compared with inhibitor treatment alone (20) .
The esteratic activity of AChE is used as a convenient and accurate reporter for both the cellular localization and level of AChE expression. However, it is important to note that the observed effects of AChE inhibitors on neurite outgrowth are independent of the ability of these compounds to inhibit esteratic activity. For example, we and others (20, 28, 29) have shown that irreversible inhibition of AChE with the organophosphate diisopropylflurophosphate (DFP) has no effect on neurite outgrowth from either CNS or PNS neurons. These studies indicate that the catalytic activity of AChE is not required for its Days in vitro 6 7 Figure 1. AChE activity increases with neurite outgrowth. Darkfield photomicrographs of DRG cultures histochemically stained for AChE activity at day 0, day 2, and day 4 after plating. Small clusters of cells within the plating area express detectable levels of AChE activity at day 2 (arrows) which becomes prominent by day 4 as a dark reaction product. This activity increases in both the cell bodies and neurites with time in culture. Quantitation of the AChE activity is shown in the lower right panel using a radiometric assay (21, 25 ented neurite outgrowth. The extent of the outgrowth is indicated by a computer-generated perimeter that was used to calculate the total outgrowth area. Antibody treatment resulted in a 50% reduction in outgrowth based on measurements from a minimum of 12 cultures obtained from three independent experiments. Panels Band Eare low magnification scanning electron micrographs taken from the outgrowth margins indicated by the boxes in A and D. Note that MAB304 treatment (B) produced a more densely interlacing pattern of outgrowth that terminates at a very uniform leading edge compared with normal lgG control (E). In addition, the growth cones are larger and restricted to the outgrowth margin in antibody-treated cultures (C). Bar in D=0.5 cm for panels A and D; bar in E=250 pm for panels Band E; bar in F=25 pm for panels Cand F. Reproduced from Bigbee and Sharma (46) (34, 37) . Other in vitro studies employing a variety of neuronal cell types have reported retardation of neurite outgrowth in response to AChE inhibitor treatment. These studies used chick tectal and retinal ganglion neurons (30), rat sympathetic ganglion neurons (28) , dopaminergic midbrain neurons (29) , spinal motor neurons (38) , and Aplysia pedal ganglion neurons (39) . These studies show that the most potent inhibitor of outgrowth was BW284c5 1, which occupies both the catalytic and the peripheral anionic sites of the active center gorge ofAChE. On the basis of the crystallographic data for AChE complexed with the AChE inhibitor decamethonium, which is also a linear, bisquaternary nitrogen compound (40) , it is likely that the BW284c5 1 molecule extends beyond the opening of the gorge. In this orientation, BW284c51 could interfere with the proposed secondary growth-related site (30) . Thus, examination of the physicochemical properties of AChE inhibitors may provide additional clues about the location and/or nature of this secondary site on AChE.
Agricultural and household pesticides that target AChE could interfere with this noncholinergic role of AChE if exposure occurs during critical periods of nervous system development. As indicated earlier, DFP has no effect on neurite growth; however, a preliminary report (41) shows that a different organophosphate compound, chlorpyrifos (Dursban), decreases neurite outgrowth in cultured PC-12 cells. In human and animal studies, prenatal exposure to chlorpyrifos produces cellular and behavioral neurotoxicity (42) (43) (44) ; in the human study (44) , CNS abnormalities were consistently noted, including structural defects in the ventricles and corpus callosum. Interestingly, young animals exhibit an increased susceptibility to organophosphorus insecticides (45) , suggesting the necessity of further study to determine if these agents pose a teratogenic threat during critical periods of gestation. Because the developmental, morphogenic role for AChE in axonal growth is now well established, current research is directed toward understanding the mechanism of action and regulation of expression of this protein.
